Eledon Pharmaceuticals- Identified Material Weakness in Internal Control Over Financial Reporting Related to Accounting for Equity Instruments
伊利登製藥-在與資產權益工具會計相關的財務報告內部控制方面確定了實質性弱點。
Eledon Pharmaceuticals- Identified Material Weakness in Internal Control Over Financial Reporting Related to Accounting for Equity Instruments
伊利登製藥-在與資產權益工具會計相關的財務報告內部控制方面確定了實質性弱點。
譯文內容由第三人軟體翻譯。